<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Curemark LLC &#8211; 元哲咨询</title>
	<atom:link href="https://www.yuanzhezixun.com/tag/curemark-llc/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.yuanzhezixun.com</link>
	<description>行业研究专家</description>
	<lastBuildDate>Fri, 11 Jan 2019 03:02:46 +0000</lastBuildDate>
	<language>zh-Hans</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://www.yuanzhezixun.com/wp-content/uploads/2021/10/cropped-shcrilogo-c-45x45.jpg</url>
	<title>Curemark LLC &#8211; 元哲咨询</title>
	<link>https://www.yuanzhezixun.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>自闭症和治疗市场报告 &#8211; 全球预测至2023年</title>
		<link>https://www.yuanzhezixun.com/zibizhenghezhiliaoshichangbaogao-quanqiuyucezhi2023nian/</link>
		
		<dc:creator><![CDATA[chrislee]]></dc:creator>
		<pubDate>Fri, 11 Jan 2019 03:02:30 +0000</pubDate>
				<category><![CDATA[医/药/保健]]></category>
		<category><![CDATA[报告速递]]></category>
		<category><![CDATA[行业资讯]]></category>
		<category><![CDATA[Allergan]]></category>
		<category><![CDATA[ASD]]></category>
		<category><![CDATA[Autism Disorder]]></category>
		<category><![CDATA[Autism treatment]]></category>
		<category><![CDATA[Bristol-Myers Squibb and Otsuka Holdings Co.]]></category>
		<category><![CDATA[Consern Pharma Private Limited]]></category>
		<category><![CDATA[Coronis Partners Ltd.]]></category>
		<category><![CDATA[Curemark LLC]]></category>
		<category><![CDATA[Eli Lilly and Company]]></category>
		<category><![CDATA[Heptares Therapeutics Limited]]></category>
		<category><![CDATA[Intra-Cellular Therapies Inc.]]></category>
		<category><![CDATA[Johnson & Johnson Services]]></category>
		<category><![CDATA[Merck & CO Inc.]]></category>
		<category><![CDATA[Novartis AG.]]></category>
		<category><![CDATA[Pfizer Inc]]></category>
		<category><![CDATA[Saniona AB]]></category>
		<category><![CDATA[Teva Pharmaceutical Industries Ltd]]></category>
		<category><![CDATA[普遍发育障碍]]></category>
		<category><![CDATA[自闭症]]></category>
		<category><![CDATA[自闭症谱系障碍]]></category>
		<category><![CDATA[阿斯伯格综合症]]></category>
		<guid isPermaLink="false">http://www.yuanzhezixun.com/?p=16956</guid>

					<description><![CDATA[预计2017 - 2023年期间全球自闭症和治疗市场将以4.37％的复合年增长率增长。<div class='yarpp yarpp-related yarpp-related-rss yarpp-related-none yarpp-template-list'>

没有相关文章
</div>
]]></description>
		
		
		
			</item>
	</channel>
</rss>
